Lin Ruitian, Wang Zhuoran, Li Zihan, Gu Lisha
Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, China.
Guangdong Provincial Key Laboratory of Stomatology, China.
Mater Today Bio. 2022 Jun 16;15:100330. doi: 10.1016/j.mtbio.2022.100330. eCollection 2022 Jun.
In clinical work, the main challenges for titanium (Ti) implantation are bacterial infection and aseptic loosening, which severely affect the survival rate of implants. The first 4 weeks post-operation is the infection peak phase of implants. Inhibiting implant infection caused by bacteria adhesion and proliferation during the early phase as well as promoting subsequent osteointegration is essential for implant success. Herein, we constructed a quaternary ammonium carboxymethyl chitosan (QCMC), collagen (COL Ⅰ) and hydroxyapatite (HAP) multilayers coating on Ti substrates via a modified layer-by-layer (LBL) technique and polymerization of dopamine. The QCMC/COL/HAP coating exhibited a multi-antibacterial property with a two-phase function: (1) At the first 4 weeks post-operation, the covalently bonded QCMC could be slowly degraded and demonstrated both contact-killing and release-killing properties during the infection peak phase; (2) At the second phase, osteogenesis and osseointegration-promotion capabilities were enhanced by HAP under the effective control of infection. The multifilm coating was degraded for more than 45 days under the action of collagenase Ⅰ, and displayed good biocompatibility and . Most importantly, the coating exhibited a long-lasting antibacterial activity for more than 3 months, against the main pathogenic bacteria of peri-implant infections. Both studies and animal models revealed a desirable osteogenic differentiation capacity of Ti-CCH. Therefore, our study reports a two-phase, long-lasting multi-antibacterial coating on Ti-CCH and indicates potential applications of the modified LBL strategy in orthopaedic fields, which is enlightening for developing practical implant and scaffold materials.
在临床工作中,钛(Ti)植入面临的主要挑战是细菌感染和无菌性松动,这严重影响植入物的存活率。术后前4周是植入物感染的高峰期。在早期抑制由细菌粘附和增殖引起的植入物感染,并促进随后的骨整合,对于植入成功至关重要。在此,我们通过改进的层层(LBL)技术和多巴胺聚合,在Ti基底上构建了季铵化羧甲基壳聚糖(QCMC)、胶原蛋白(COLⅠ)和羟基磷灰石(HAP)多层涂层。QCMC/COL/HAP涂层具有多抗菌性能,具有两相功能:(1)在术后前4周,共价结合的QCMC可缓慢降解,并在感染高峰期表现出接触杀灭和释放杀灭性能;(2)在第二阶段,在有效控制感染的情况下,HAP增强了成骨和促进骨整合的能力。该多层膜涂层在Ⅰ型胶原酶作用下可降解超过45天,并表现出良好的生物相容性。最重要的是,该涂层对种植体周围感染的主要病原菌具有超过3个月的持久抗菌活性。体外研究和动物模型均显示Ti-CCH具有理想的成骨分化能力。因此,我们的研究报道了一种在Ti-CCH上的两相、持久的多抗菌涂层,并指出了改进的LBL策略在骨科领域的潜在应用,这对开发实用的植入物和支架材料具有启发性。